NOBORI 1 - NOBORI 1

Description:

The goal of the trial was to evaluate the Nobori stent, a stent that elutes biolimus A9, a rapamycin derivative, compared with paclitaxel-eluting stents (PES) among patients undergoing percutaneous coronary intervention (PCI) for de novo coronary lesions.